Featured Headlines Feed for RPRX Headlines for Repros Therapeutics, Inc. http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11919096/1/biotech-stock-mailbag-synta-zogenix-sarepta-amarin.html.aspx?puc=aol&cm_ven=aol TheStreet Fri, 10 May 2013 07:00:00 GMT Repros Patent Problems Began When Harry Met Joe http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11918232/1/repros-patent-problems-began-when-harry-met-joe.html.aspx?puc=aol&cm_ven=aol TheStreet Thu, 09 May 2013 08:00:00 GMT Shorts Are Covering These 4 Highly Shorted, Cash-Rich Small Caps http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1361151-shorts-are-covering-these-4-highly-shorted-cash-rich-small-caps.aspx Seeking Alpha Tue, 23 Apr 2013 09:10:04 GMT Repros Gets Additional Patents - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96992/repros-gets-additional-patents.aspx Zacks Fri, 12 Apr 2013 16:40:01 GMT 5 Stocks To Watch Next Week For Gains http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1324871-5-stocks-to-watch-next-week-for-gains.aspx Seeking Alpha Sun, 07 Apr 2013 03:32:23 GMT Positive Data on Repros' Androxal - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96334/positive-data-on-repros-androxal.aspx Zacks Thu, 04 Apr 2013 16:43:01 GMT Can Repros Therapeutics Maintain Its Momentum? http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1321121-can-repros-therapeutics-maintain-its-momentum.aspx Seeking Alpha Thu, 04 Apr 2013 13:14:12 GMT Up 76% Overnight With Room to Run http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/28/up-76-overnight-with-room-to-run/.aspx DailyFinance Thu, 28 Mar 2013 17:49:00 GMT Repros CEO: My Testosterone Drug Helped Gay Cubans Have Lots of Sex http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11882690/1/repros-ceo-my-testosterone-drug-helped-gay-cubans-have-lots-of-sex.html.aspx?puc=aol&cm_ven=aol TheStreet Thu, 28 Mar 2013 12:10:00 GMT Thursday movers: BlackBerry up on surprise profit http://www.fool.com/news/xt/marketwatch/www.marketwatch.com/story/thursdays-movers-blackberry-accenture-2013-03-28.aspx?mod=247wallst MarketWatch Thu, 28 Mar 2013 10:36:04 GMT Morning Market Movers http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3454869/morning-market-movers.aspx Benzinga Thu, 28 Mar 2013 10:09:43 GMT Repros Reports Both Primary Endpoints Successfully Met in Androxal Study http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3452865/repros-reports-both-primary-endpoints-successfully-met-in-androxal-study.aspx Benzinga Wed, 27 Mar 2013 21:45:49 GMT Repros Therapeutics ZA-301 Study: Odds Of Success Have Just Increased http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1269891-repros-therapeutics-za-301-study-odds-of-success-have-just-increased.aspx Seeking Alpha Wed, 13 Mar 2013 11:20:46 GMT Repros Therapeutics Says FDA Granted End of Phase 2 Meeting in Late May to Discuss Proellex(R)-V Pha http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3377293/repros-therapeutics-says-fda-granted-end-of-phase-2-meeting-in-late-may-to-discus.aspx Benzinga Thu, 28 Feb 2013 09:29:11 GMT This Week in Biotech http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/23/this-week-in-biotech-16/.aspx DailyFinance Sat, 23 Feb 2013 12:00:00 GMT Repros Soars -- and AbbVie Might Suffer http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/21/repros-soars-and-abbvie-might-suffer/.aspx DailyFinance Thu, 21 Feb 2013 16:25:00 GMT U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130221-000495&cid=1244 Smart Money Thu, 21 Feb 2013 09:05:00 GMT Repros Blasts Off After FDA Study Clearance http://www.fool.com/news/xt/247wallst/247wallst.com/2013/02/21/repros-blasts-off-after-fda-study-clearance/.aspx 247wallst Thu, 21 Feb 2013 08:15:20 GMT A Peek Into The Market Before The Trading Starts http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3353006/a-peek-into-the-market-before-the-trading-starts.aspx Benzinga Thu, 21 Feb 2013 07:19:54 GMT Repros Says FDA Recommends Pivotal Study ZA-301 of Androxal to be Completed as Originally Planned http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3352952/repros-says-fda-recommends-pivotal-study-za-301-of-androxal-to-be-completed-as-or.aspx Benzinga Thu, 21 Feb 2013 07:13:44 GMT